REGENTATLANTIC CAPITAL LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
REGENTATLANTIC CAPITAL LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2022$229,000
+9.0%
3,0150.0%0.01%0.0%
Q2 2022$210,000
-16.0%
3,0150.0%0.01%0.0%
Q1 2022$250,000
+10.6%
3,0150.0%0.01%
+16.7%
Q4 2021$226,000
-35.4%
3,0150.0%0.01%
-45.5%
Q3 2021$350,000
-47.7%
3,015
-0.1%
0.01%
-47.6%
Q2 2021$669,000
+67.7%
3,0180.0%0.02%
+61.5%
Q1 2021$399,000
-27.3%
3,018
-4.9%
0.01%
-40.9%
Q4 2020$549,000
+17.1%
3,175
-24.7%
0.02%
+4.8%
Q3 2020$469,000
+91.4%
4,215
+2.1%
0.02%
+50.0%
Q2 2020$245,000
-11.6%
4,127
+0.4%
0.01%
-36.4%
Q1 2020$277,000
-34.2%
4,112
-17.8%
0.02%
-15.4%
Q4 2019$421,000
+12.6%
5,0000.0%0.03%
+4.0%
Q3 2019$374,000
+18.4%
5,0000.0%0.02%
+19.0%
Q2 2019$316,000
+28.5%
5,000
-2.2%
0.02%
+23.5%
Q1 2019$246,000
+2.5%
5,112
-28.8%
0.02%
-15.0%
Q4 2018$240,000
-35.1%
7,181
+1.6%
0.02%
-28.6%
Q3 2018$370,000
+67.4%
7,0690.0%0.03%
+47.4%
Q2 2018$221,000
-43.3%
7,069
-63.4%
0.02%
-40.6%
Q4 2017$390,000
+1.8%
19,2940.0%0.03%
-3.0%
Q3 2017$383,000
+14.7%
19,2940.0%0.03%
+10.0%
Q2 2017$334,000
+114.1%
19,2940.0%0.03%
+114.3%
Q1 2017$156,000
+3.3%
19,2940.0%0.01%
-6.7%
Q4 2016$151,000
-8.5%
19,2940.0%0.02%
-11.8%
Q3 2016$165,000
-26.7%
19,2940.0%0.02%
-22.7%
Q2 2016$225,00019,2940.02%
Other shareholders
NOVOCURE LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders